Melanoma/Skin Cancer News
- Pembrolizumab Plus Low-Dose Ipilimumab Safe in Melanoma, Renal Cell Carcinoma
- Major advance in melanoma drug combinations
News feed below courtesy of Medical News Today and :MedWorm
News feed below courtesy of Medical News Today and :MedWorm